Skip to main content
. 2022 Oct 7;42(10):BSR20220368. doi: 10.1042/BSR20220368

Table 4. Top characterized OASS chemical inhibitors.

Inhibitor Enzyme IC50 (µM)* KD (µM)* Citation
Cyclopropyl derivative 7 (UPAR40) HiCysK 700 ± 53 1.46 ± 0.25 [114]
Cyclopropyl derivative 17 ND 1.45† [117]
Cyclopropane carboxylic acid 14b (UPAR415) StCysK ND 0.028 ± 0.005 [117]
StCysM ND 0.49 ± 0.05 [117]
Cyclopropane carboxylic acid 15b StCysK 0.099 ± 0.004 0.054 ± 0.008 [117]
StCysM 0.50 ± 0.03 0.42 ± 0.06 [117]
8a StCysK ND [123]
StCysM ND [123]
9e StCysK ND 0.035 ± 0.003 [123]
StCysM ND 0.61 ± 0.08 [123]
9f StCysK ND 0.051 ± 0.004 [123]
StCysM ND 1.45 ± 0.31 [123]
12h StCysK ND [123]
StCysM ND [123]
13h StCysK ND 0.066 ± 0.005 [123]
StCysM ND 3.37 ± 0.72 [123]
21i StCysK ND 0.45 ± 0.09 [123]
StCysM ND 83.8 ± 16.1 [123]
21j StCysK ND 0.25 ± 0.06 [123]
StCysM ND 23.6 ± 4.5 [123]
Trifluoroalanine StCysK 130 ± 10 ND [122]
StCysM 1290 ± 230 ND [122]
Benzoic acid 87 MtbCysK1 0.019 ± 0.0011 ND [121]
Benzoic acid 1 MtbCysM ND 0.32 ± 0.01 [7]
Benzoic acid 2 MtbCysK2 ND 22.6 ± 2.4 [7]

ND = not determined.

*

Error reported as standard error.

No error reported.